SAE and SUSAR Management
Fast, compliant, and globally consistent case processing that safeguards patients and strengthens regulatory confidence.
Serious Adverse Events (SAEs) and Suspected Unexpected Serious Adverse Reactions (SUSARs) demand rapid, accurate, and compliant handling. Qinecsa delivers a fully integrated SAE and SUSAR Management solution that ensures every case is captured, assessed, processed, and reported within global regulatory timelines—without compromising scientific rigor or patient safety.
Our global pharmacovigilance experts combine deep clinical understanding with advanced technology to streamline case intake, medical review, and expedited reporting.
Talk to a PV Specialist
What Is SAE And SUSAR Management And Why It Matters
SAE and SUSAR Management refers to the end‑to‑end process of capturing, evaluating, documenting, and reporting serious adverse events and unexpected reactions during clinical development. These events carry significant regulatory, operational, and patient safety implications, making accuracy and speed essential.
Pharma and biotech organizations face increasing pressure to meet global expedited reporting timelines, maintain data quality, and ensure consistent processes across regions and partners. Qinecsa helps you overcome these challenges with a scalable, technology‑enabled solution that delivers precision, efficiency, and compliance.
With Qinecsa, you gain:
- Rapid, accurate SAE and SUSAR processing
- Confidence in global regulatory compliance and reporting timelines
- Inspection‑ready documentation and audit‑proof workflows
- Improved operational efficiency and reduced risk
- Stronger patient safety oversight across all clinical programs
How SAE And SUSAR Management Fits Into Your Wider PV Strategy
SAE and SUSAR management is a critical component of clinical safety oversight. It connects case processing, medical review, signal detection, and regulatory reporting into a unified safety framework. Qinecsa ensures your SAE and SUSAR processes integrate seamlessly with your broader pharmacovigilance system, supporting both operational excellence and regulatory success.
Talk to a PV Specialist
Why Qinecsa For SAE And SUSAR Management
Choosing Qinecsa means partnering with a global pharmacovigilance leader that understands the scientific, operational, and regulatory demands of SAE and SUSAR Management. Our approach blends expertise, technology, and global insight to deliver fast, compliant, and high‑quality case processing.
Deep PV and Clinical Safety Expertise
Our teams include experienced PV scientists, physicians, and case processing specialists who understand the nuances of SAE assessment, causality, and expedited reporting.
Technology Enabled Case Processing
We leverage advanced platforms, automation, and structured workflows to ensure accuracy, consistency, and efficiency across all SAE and SUSAR activities.
Global and Local Regulatory Insight
With specialists across the EU, US, and emerging markets, we ensure your reporting meets region specific requirements and evolving regulatory expectations. Proven experience in audits, inspections, and compliance documentation.
Integration with other services
Alignment with Responsible Person for Pharmacovigilance (RPPV)/ Responsible Person for EudraVigilance (RPEV), QPPV, clinical safety management, and PV audits for holistic oversight. Flexible, scalable model: Services adapted to study size, phase, and complexity.
Qinecsa’s Approach To SAE And SUSAR Management
Our methodology ensures speed, scientific rigor, and regulatory alignment throughout the SAE and SUSAR lifecycle.
Rapid Case Intake
We capture and triage cases quickly using structured workflows and technology‑enabled intake channels.
Accurate Medical Assessment
Our medical reviewers evaluate seriousness, causality, and expectedness with scientific precision and regulatory alignment.
Compliant Expedited Reporting
We ensure timely submissions to global authorities, ethics committees, and investigators.
Lifecycle Documentation
Qinecsa maintains complete, inspection‑ready records that support audits, inspections, and regulatory queries.
Key Features Of Our SAE And SUSAR Management Solution
For Your Organization
- Stronger regulatory compliance
- Reduced operational and safety risk
- Efficient, technology‑supported workflows
- Consistent global reporting and documentation
For Internal Teams
- Clear processes and responsibilities
- Confidence in regulatory timelines
- Improved collaboration across clinical and safety teams
For Patients & Healthcare Professionals
- Faster detection of safety issues
- Stronger protection through timely reporting
- Improved communication of critical safety information
Benefits of SAE And SUSAR Management With Qinecsa
For Your Organization
- Inspection‑ready case documentation
- Reduced regulatory findings
- Streamlined SAE and SUSAR lifecycle management
- Harmonized global safety processes
For Internal Teams
- Clear visibility into case status
- Confidence in expedited reporting
- Better alignment across clinical and PV functions
For Patients & Healthcare Professionals
- Enhanced safety monitoring
- Faster response to emerging risks
- More effective communication of serious safety concerns
FAQs - SAE And SUSAR Management
It is the structured oversight, assessment, and reporting of serious adverse events (SAEs) and suspected unexpected serious adverse reactions (SUSARs) in clinical trials. Qinecsa ensures timely, compliant, and audit-ready management of all events.
Effective management safeguards patient safety, maintains regulatory compliance, and reduces operational risk. It enables senior leaders to make informed, timely decisions regarding trial continuation or modification.
Our team follows EMA, MHRA, FDA, and ICH guidelines, producing audit-ready documentation and supporting timely submission of SUSAR reports to authorities.
Yes, Qinecsa’s service is designed to complement clinical safety management, QPPV oversight, and PV audits for a fully integrated safety governance approach.
Dedicated case managers, clinical safety physicians, and PV experts supported by centralised reporting platforms for accurate and timely processing of all events.
By detecting, assessing, and reporting serious events quickly, risks are mitigated sooner, protecting trial participants and supporting patient confidence.
Yes, Qinecsa adapts service levels to meet the demands of multi-country studies and complex programmes.
All SAE and SUSAR processes are fully documented, traceable, and aligned with regulatory expectations to facilitate inspections and sponsor oversight.
Yes, Qinecsa centralises management, standardises workflows, and provides expert guidance, freeing internal teams to focus on strategic decision-making.
Our combination of PV expertise, technology-enabled workflows, global regulatory insight, and integrated services ensures robust safety governance at scale.
Talk to a PV Specialist
Accurate, fast, and compliant SAE and SUSAR Management is essential for protecting patients and meeting global regulatory expectations. Qinecsa’s experts are ready to support your organization with end‑to‑end case processing, medical review, and expedited reporting.